Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Similar documents
Understanding Your Genetic Test Result. Positive for Two Copies of an MYH Mutation

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Hereditary Colorectal Cancer

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

What a history of cancer may mean for you and your family and the steps you can take to reduce the risk

POSITIVE DELETERIOUS MUTATION

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

A Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?

Understanding Your Positive Result. A guide to understanding your risk and taking action

Does Cancer Run in Your Family?

The Genetics of Familial Polyposis

An Introduction to MUTYH Associated Polyposis (MAP)

Pathology reports, related operative reports and consult letters must be provided with a request for assessment.

Primary Care Approach to Genetic Cancer Syndromes

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

Result Navigator. Positive Test Result: BMPR1A. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department

Cancer Genomics 101. BCCCP 2015 Annual Meeting

12: BOWEL CANCER IN FAMILIES

PENETRANCE ACTIONABILITY SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above) YES (Proceed to Stage II)

Familial Adenomatous Polyposis

Information for You and Your Family

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

Myriad Financial Assistance Program (MFAP)

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

Result Navigator. Positive Test Result: CDH1. After a positive test result, there can be many questions about what to do next. Navigate Your Results

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

Result Navigator. Positive Test Result: STK11. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Familial and Hereditary Colon Cancer

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

Result Navigator. Positive Test Result: PTEN. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Familial and Hereditary Colon Cancer

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University

What All of Us Should Know About Cancer and Genetics

We Care Questionnaire please complete and return to your provider

Result Navigator Positive Test Result: MSH6

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome

PATIENT BROCHURE. 441 Charmany Dr 1 Madison WI, RX Only

Classification of polyposis syndromes two major groups. Adenomatous polyposis syndromes. Hamartomatous polyposis syndromes

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

Are you at risk of Hereditary Cancer? Your Guide to the Answers

YES NO UNKNOWN. Stage I: Rule-Out Dashboard ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above)

Hereditary Cancer Products

2012 update. Bowel Cancer. Information for people at increased risk of bowel cancer. Published by the New Zealand Guidelines Group

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

The Next Generation of Hereditary Cancer Testing


COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi

Hereditary Cancer Risk Testing: What to Expect

Robert Nathan Slotnick MD PhD FACOG FACMG (FF) Perinatologist and Director Medical Genetics

GI EMERGENCIES Acute Abdominal Pain

Incorporating Hereditary Cancer Risk Assessment into Your Practice

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING

Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care

Genetic Risk Evaluation and Testing Program

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer

1101 First Colonial Road, Suite 300, Virginia Beach, VA Phone (757) Fax (757)

Caring for Patients at Risk for Hereditary Colorectal Cancer

Endoscopic techniques for surveillance and treatment of FAP

Colorectal Cancer Screening

FREQUENTLY ASKED QUESTIONS

Colorectal Cancer in 2006: New Developments

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Result Navigator. Positive Test Result: CDKN2A. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Razvan I. Arsenescu, MD Assistant Professor of Medicine Division of Digestive Diseases EARLY DETECTION OF COLORECTAL CANCER

I have ovarian cancer

Rx Only. Detecting Cancer In Blood.

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018

EARLY DETECTION OF COLORECTAL CANCER. Epidemiology of CRC

Duodenal adenomas Management. Dr Stratis Alexandridis Consultant Gastroenterologist BRI

Hereditary GI tumor syndromes ACG guidelines of genetic testing and management. Dr. med. Henrik Csaba Horváth PhD

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

Screening & Surveillance Guidelines

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

FAMILIAL ADENOMATOUS POLYPOSIS (COLORECTAL CANCER) PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 4: Colorectal Cancer Overview

Disclosure. Agenda. I do not have any relevant financial/non financial relationships with any proprietary interests

LET S TALK ABOUT CANCER

Chapter 18 Section 13

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond.

2017 CANCER ANNUAL REPORT

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696

Transcription:

Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious

This workbook is designed to help you understand the results of your genetic test and is best reviewed with your healthcare provider. Please verify that your test result matches the following information by looking at the patient copy of your test result or contacting the healthcare provider who ordered your test. If your test result does not match, please disregard this brochure, and contact your healthcare provider. Overview of FAP and AFAP Mutations in APC cause one of two adenomatous polyposis syndromes: familial adenomatous polyposis (FAP) or attenuated familial adenomatous polyposis (AFAP). These syndromes are associated with the development of varying numbers of adenomas (pre-cancerous polyps) in the colon and rectum. Familial Adenomatous Polyposis (FAP) Attenuated FAP (AFAP) Number of Colorectal Adenomas (Polyps) Hundreds to thousands Between 10 and 99 over a lifetime FAP and AFAP also lead to an increased risk of colon/rectal (colorectal) cancer and, in some cases, other types of cancer. Overview of Your Test Result You have a mutation or alteration in the APC gene. You have an adenomatous polyposis syndrome (either FAP or AFAP, depending on the number of colorectal adenomas). FAP and AFAP increase the risk of colorectal adenomas/cancer, and in some cases, other types of cancer. The risk of developing these cancers is less than 100%. Not everyone with FAP or AFAP will develop cancer. Your Cancer Risks Having FAP or AFAP increases the risk of certain cancers. Colorectal cancer risks by age 70 Mutation Carrier General Population FAP ~100 2% AFAP 80-100% 2% Your Genetic Test Result (check the appropriate boxes below) THE GENETIC TEST YOU RECEIVED q COLARIS AP PLUS : Full sequence and large rearrangement analysis of the APC and MYH genes. q Gene-Specific COLARIS AP APC Analysis: Full sequence and large rearrangement analysis of the APC gene. q Single Site COLARIS AP: Mutation-specific analysis for individuals with a known APC gene mutation in the family. YOUR TEST RESULT Other cancer risks by age 70* Mutation Carrier General Population Duodenal cancer 4-12% <1% Thyroid cancer ~2% <1% Pancreatic cancer ~2% <1% Hepatoblastoma (liver cancer in children) 1.6% <1% Brain cancer <1% <0.6% Stomach cancer 0.6% <1% * Less information is available about the risks of these cancers than about colorectal cancer. q Positive for a Deleterious Mutation q Genetic Variant, Suspected Deleterious 2 3

Managing Your Risks* Options for reducing cancer risk are available whether or not you have already had a diagnosis of cancer and/or adenomas. The following are medical management guidelines for individuals with FAP and AFAP. Discuss these options with the appropriate medical professionals to determine how you will manage your cancer risks. INCREASED SURVEILLANCE SITE PROCEDURE AGE TO BEGIN REPEAT Colon FAP Colon AFAP Colon After colon surgery Duodenum and stomach Thyroid Sigmoidoscopy or colonoscopy Colonoscopy Endoscopy of remaining rectum, ileal pouch or ileostomy Baseline upper endoscopy (including side-viewing examination) Physical exam and consideration of ultrasound 10-15 years Annually Late teens or early 20s (depending on age of polyp development in the family) After colon surgery 1-3 years 6 months to 3 years (depending on number of polyps on previous exam) 20-25 years 1-4 years Late teens *For references and supporting data on risk factors and medical management, visit www.myriadpro.com/references Annually Screening for other related cancers (brain, pancreatic, hepatoblastoma, etc.) may be considered. Please speak to your healthcare provider about this option. SURGICAL MANAGEMENT FAP Preventive removal of the colon and rectum is recommended. The timing of surgery is based on the number/size of polyps. AFAP Preventive removal of the colon and rectum may be recommended depending on the number of polyps. It s a Family Affair APC mutations are passed on in a family. Now that a mutation has been identified in you: Your close blood relatives (parents, children, brothers, and sisters) have a 50% chance of having the same mutation. More distant relatives (cousins, uncles, and aunts) also have a chance of having the mutation that runs in your family. Generally, the mutation is only going to be found on the side of your family (father s or mother s) that has the history of cancer and/or adenomas. NOTE: If you have no family history of adenomas (polyps) and/or cancer, it is possible the APC mutation is new in you. Your parents can be tested for your mutation to confirm that this is the case. In this situation, your children have a 50% chance of having the same APC mutation and there is a small chance that your brothers and sisters might also have the mutation. However, your more distant relatives are not at-risk. Your relatives can be offered Single Site COLARIS AP to determine whether or not they have the same mutation. Relatives interested in genetic testing will need to know your specific mutation. It is best to provide your relatives with a copy of your test result which you can obtain from your healthcare provider. If your relative is: u Positive for the mutation, he/she has the increased cancer risks associated with FAP or AFAP and can benefit from appropriate medical management. u Negative for the mutation, he/she has an average risk of cancer and can follow general population screening guidelines. Your healthcare provider can assist in determining which of your relatives should consider genetic testing. Myriad has resources available to help you with your genetic test result. Contact Myriad s Medical Services Department at 800-469-7423 for: u Answers to questions about your test result. u Information about genetic testing for your relatives. Or, visit Myriad s website for: u A sample letter that can be sent to relatives who may need genetic testing can be found at www.myriadtests.com/lettercoap1positive. u A healthcare provider who can offer genetic testing to relatives in any state can be found at www.myriadtests.com/findadoctor. If you need a copy of your genetic test result, please contact the healthcare provider who ordered your test. CHEMOPREVENTION N Drugs may be used to reduce the number of polyps in any rectum that remains after colon surgery. 4 5

Next Steps Please work with your healthcare provider to determine the most appropriate next steps for you. q Obtain a copy of your test result. q Schedule consultations with appropriate healthcare providers (list below). q Create a plan for medical management. q Consider sharing your genetic test result with your relatives. q Re-contact your healthcare provider on a regular basis for new information. Additional Resources Colon Cancer Alliance A national patient advocacy organization dedicated to ending the suffering caused by colorectal cancer. www.ccalliance.org 877-422-2030 Colorectal Cancer Coalition A national organization whose mission is to eliminate suffering and death due to colorectal cancer. www.c-three.org 202-244-2906 Myriad Genetic Laboratories, Inc. www.myriadtests.com 800-4-MYRIAD (800-469-7423) E-mail: helpmed@myriad.com 6 7

MySupport360.com Myriad Genetic Laboratories, Inc. 320 Wakara Way Salt Lake City, UT 84108 800-469-7423 Myriad, the Myriad logo, COLARIS AP, the COLARIS AP logo, MySupport360, and the MySupport360 logo are either trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and other jurisdictions. THIS INFORMATION IS PROVIDED TO HELP ANSWER SOME OF YOUR QUESTIONS WITH RESPECT TO CANCER RISKS, HEREDITARY CANCER RISKS, AND PRE-DISPOSITIONAL CANCER TESTING. IT IS GENERAL IN NATURE AND IS NOT INTENDED TO PROVIDE A DEFINITIVE ANALYSIS OF YOUR SPECIFIC RISK FACTORS FOR CANCER OR YOUR HEREDITARY CANCER RISKS. YOU SHOULD NOT RELY ON THE INFORMATION PROVIDED HEREIN; BUT RATHER, YOU SHOULD CONSULT WITH YOUR DOCTOR OR A QUALIFIED HEALTHCARE PROFESSIONAL TO REVIEW THIS INFORMATION ALONG WITH YOUR INDIVIDUAL HEALTH CONDITIONS AND RISK FACTORS. 2013, Myriad Genetic Laboratories, Inc. COAP1Pos/02-13 COAP1Positive